Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

WASHINGTON (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75-million penalty to settle Securities ...

Cantor Fitzgerald CEO Howard Lutnick is co-chair of the transition team for Donald Trump. The SEC says his firm caused two ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $14.99 which represents a slight increase of $0.22 or 1.49% from the prior close of $14.77. The stock opened at $14.9 ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

After Cantor Fitzgerald got an earlier ruling from the Delaware Supreme Court finding the forfeiture-for-competition provisions of its partnership agreements valid under state law, Benjamin Nagin ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...